Oura has announced the acquisition of Counsel Health, an AI-driven primary care platform, for $625 million. This strategic move follows Oura's decision to indefinitely postpone its planned IPO, which was valued at up to $2.2 billion, due to market instability.
Counsel Health provides a medical platform that integrates chat-based AI advice with access to licensed physicians. The service was already integrated into the Oura application in June. The companies intend to broaden their collaboration to cover preventative, acute, specialty, and chronic care services.
Counsel Health previously raised $36 million in total funding, including a $25 million Series A round led by Andreessen Horowitz and GV. Following the acquisition, Counsel CEO Muthu Alagappan will join Oura as chief clinical AI officer, along with the startup's 70 employees.
Oura reported significant financial growth, with revenue reaching $533 million for the quarter ending September 30, a 153% year-over-year increase. For the 2026 fiscal year, the company generated approximately $1.75 billion in revenue, reflecting 92% growth compared to the previous year.
The company currently holds a valuation of $11 billion, established after a $900 million late-stage funding round in October 2025. Oura aims to use the acquisition to expand its care model beyond its existing membership base to new enterprise partners.
